FEATURED NEWS
Reminder: 4 days to Brexit Event!
Our CEO Ann McGee will be speaking at the Pharma and Brexit Conference – hosted by PDA Ireland and PDA United Kingdom.
The event will focus on the impact, challenges and solutions for the pharmaceutical industry.
Extension of the comment period by FDA
FDA Proposed Rule "National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers" In February 2022, the FDA has
GMP/GDP Audits & the Importance of CAPA
The conduct of audits is a key part of our Pharmaceutical Quality Systems to give us information on the activities and
Brexit and the Evolving Impact on the Pharmaceutical World
Brexit took place at 11pm on 31 Jan 2020 as the UK departed from the European Union. A transition period of
What should be taken into consideration when assessing suppliers?
Wholesalers must ensure that their suppliers are permitted to supply pharmaceuticals. Legal History The following is applicable in accordance with chapter 5.2 of the
QP Audits to ensure GxP Standards
Introduction For any organisation that plays a role in the supply of pharmaceutical products such as manufacturing, QC
Reminder: 4 days to BREXIT Event!
Our CEO Ann McGee will be speaking at the Pharma and Brexit Conference - hosted by PDA Ireland and PDA United
We Welcome our New CEO Pierre-Henri Baviera
We are very excited to announce the appointment of Pierre-HenriBaviera as the new CEO for Mias Pharma
Extension of the comment period by FDA
FDA Proposed Rule "National Standards for the Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers" In February 2022, the FDA has announced the availability
GMP/GDP Audits & the Importance of CAPA
The conduct of audits is a key part of our Pharmaceutical Quality Systems to give us information on the activities and standards to which
Brexit and the Evolving Impact on the Pharmaceutical World
Brexit took place at 11pm on 31 Jan 2020 as the UK departed from the European Union. A transition period of 11 months began